Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study

BMC Public Health

Orin S Levine³  David Bishai⁵  William J Moss²  Hassan M Al-Emran¹  Mohammed S Shomik⁴  Kyla T Hayford³ 

[1]Child Health Research Foundation (CHRF), Dhaka Shishu Hospital, Dhaka 1212, Bangladesh

[2]Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA

[3]Department of International Health, International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health, 855 N. Wolfe Street, Suite 600, Baltimore, MD 21205, USA

[4]International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, Dhaka 1212, Bangladesh

[5]Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, 615 N. Wolfe Street, Baltimore, MD 21205, USA

关键词: Bangladesh;    Maternal report;    Vaccination card;    Oral fluid;    Measles;    Surveillance;    Immune marker;    Vaccination;    Immunization;   

Others  :  1161413
DOI  :  10.1186/1471-2458-13-1211

 received in 2013-02-19, accepted in 2013-12-12,  发布年份 2013

【 摘 要 】

Background

Recent outbreaks of measles and polio in low-income countries illustrate that conventional methods for estimating vaccination coverage do not adequately identify susceptible children. Immune markers of protection against vaccine-preventable diseases in oral fluid (OF) or blood may generate more accurate measures of effective vaccination history, but questions remain about whether antibody surveys are feasible and informative tools for monitoring immunization program performance compared to conventional vaccination coverage indicators. This study compares six indicators of measles vaccination status, including immune markers in oral fluid and blood, from children in rural Bangladesh and evaluates the implications of using each indicator to estimate measles vaccination coverage.

Methods

A cross-sectional population-based study of children ages 12–16 months in Mirzapur, Bangladesh, ascertained measles vaccination (MCV1) history from conventional indicators: maternal report, vaccination card records, ‘card + history’ and EPI clinic records. Oral fluid from all participants (n = 1226) and blood from a subset (n = 342) were tested for measles IgG antibodies as indicators of MCV1 history and compared to conventional MCV1 coverage indicators.

Results

Maternal report yielded the highest MCV1 coverage estimates (90.8%), followed by EPI records (88.6%), and card + history (84.2%). Seroprotection against measles by OF (57.3%) was significantly lower than other indicators, even after adjusting for incomplete seroconversion and assay performance (71.5%). Among children with blood results, 88.6% were seroprotected, which was significantly higher than coverage by card + history and OF serostatus but consistent with coverage by maternal report and EPI records. Children with vaccination cards or EPI records were more likely to have a history of receiving MCV1 than those without cards or records. Despite similar MCV1 coverage estimates across most indicators, within-child agreement was poor for all indicators.

Conclusions

Measles IgG antibodies in OF was not a suitable immune marker for monitoring measles vaccination coverage in this setting. Because agreement between conventional MCV1 indicators was mediocre, immune marker surveillance with blood samples could be used to validate conventional MCV1 indicators and generate adjusted results that can be compared across indicators.

【 授权许可】

   
2013 Hayford et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]WHO: GIVS: global immunization vision and strategy 2006–2015. Geneva: WHO; 2005.
• [2]United Nations Development Programme: Millennium Development Goals (MDGs). http://www.undp.org/content/undp/en/home/mdgoverview/ webcite
• [3]Bos E, Batson A: Using immunization coverage rates for monitoring health sector performance: Measurement and interpretation issues. In Health, Nutrition and Population (HNP) Discussion Papers. Edited by Bank W. Washington, DC; 2000.
• [4]Bolton P, Holt E, Ross A, Hughart N, Guyer B: Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep 1998, 113:521-526.
• [5]Goldman N, Pebley AR: Health cards, maternal reports and the measurement of immunization coverage: the example of Guatemala. Soc Sci Med 1994, 38:1075-1089.
• [6]Luman ET, Ryman TK, Sablan M: Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall. Vaccine 2009, 27:2534-2539.
• [7]Rodewald L, Maes E, Stevenson J, Lyons B, Stokley S, Szilagyi P: Immunization performance measurement in a changing immunization environment. Pediatrics 1999, 103:889-897.
• [8]Suarez L, Simpson DM, Smith DR: Errors and correlates in parental recall of child immunizations: effects on vaccination coverage estimates. Pediatrics 1997, 99:E3.
• [9]Valadez JJ, Weld LH: Maternal recall error of child vaccination status in a developing nation. Am J Public Health 1992, 82:120-122.
• [10]Murray CJ, Shengelia B, Gupta N, Moussavi S, Tandon A, Thieren M: Validity of reported vaccination coverage in 45 countries. Lancet 2003, 362:1022-1027.
• [11]Lim SS, Stein DB, Charrow A, Murray CJ: Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008, 372:2031-2046.
• [12]Borgdorff MW, Walker GJ: Estimating vaccination coverage: routine information or sample survey? J Trop Med Hyg 1988, 91:35-42.
• [13]Zuber PL, Yameogo KR, Yameogo A, Otten MW Jr: Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. J Infect Dis 2003, 187:S86-90.
• [14]Huhn GD, Brown J, Perea W, Berthe A, Otero H, LiBeau G, Maksha N, Sankoh M, Montgomery S, Marfin A, et al.: Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons–Liberia, 2004. Vaccine 2006, 24:730-737.
• [15]WHO: WHO Immunization Coverage Cluster Survey - Reference Manual. Geneva, Switzerland: World Health Organization; 2005.
• [16]Brown J, Monasch R, Bicego G, Burton A, Boerma J: An assessment of the quality of national child immunization coverage estimates in population-based surveys. USAID: Measure Evaluation; 2002.
• [17]Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, Wolfson L, Jones G, Birmingham M: WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009, 87:535-541.
• [18]Tapia MD, Pasetti MF, Cuberos L, Sow SO, Doumbia MN, Bagayogo M, Kotloff KL, Levine MM: Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys. Pediatr Infect Dis J 2006, 25:819-825.
• [19]Vancelik S, Guraksin A, Ayyildiz A, Beyhun NE: Seroepidemiology of poliovirus antibody among the children in Eastern Turkey. Indian J Med Res 2007, 126:528-533.
• [20]Ohuma EO, Okiro EA, Bett A, Abwao J, Were S, Samuel D, Vyse A, Gay N, Brown DWG, Nokes DJ: Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 2009, 137(2):227-233.
• [21]Kremer JR, Muller CP: Evaluation of commercial assay detecting specific immunoglobulin g in oral fluid for determining measles immunity in vaccinees. Clin Diagn Lab Immunol 2005, 12:668-670.
• [22]Filmer D, Pritchett L: Estimating wealth effects without expenditure data–or tears: an application to educational enrollments in states of India. Demography 2001, 38:115-132.
• [23]Vyse AJ, Cohen BJ, Ramsay ME: A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001, 115:201-207.
• [24]Microimmune website. http://www.microimmune.co.uk/new/measles_IgG_cap.htm webcite
• [25]Siemens Enzygnost Anti-Measles Virus IgG Manual. http://www.healthcare.siemens.com/infectious-disease-testing/systems/bep-iii-system/assays webcite
• [26]National Institute of Population Research and Training (NIPORT) MaA, and ORC Macro: Bangladesh demographic and health survey 2004. Maryland, USA: Dhaka, Bangladesh and Calverton; 2005.
• [27]Measles-Rubella Surveillance and Outbreak Investigation. http://www.searo.who.int/entity/immunization/documents/9789290223504/en/ webcite
• [28]Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P: Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010, 340:c1626.
• [29]Halsey NA, Boulos R, Mode F, Andre J, Bowman L, Yaeger RG, Toureau S, Rohde J, Boulos C: Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med 1985, 313:544-549.
• [30]EPI: Bangladesh EPI coverage evaluation survey 2009. Dhaka, Bangladesh: Expanded Programme on Immunization; 2009.
• [31]Hayford KT, Al-Emran HM, Moss WJ, Shomik M, Bishai D, Levine O: Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. J Virol Methods 2013, 193:512-518.
• [32]Corsi DJ, Bassani DG, Kumar R, Awasthi S, Jotkar R, Kaur N, Jha P: Gender inequity and age-appropriate immunization coverage in India from 1992 to 2006. BMC Int Health Hum Rights 2009, 9(Suppl 1):S3. BioMed Central Full Text
• [33]Kumar D, Aggarwal A, Gomber S: Immunization status of children admitted to a tertiary-care hospital of north India: reasons for partial immunization or non-immunization. J Health Popul Nutr 2010, 28:300-304.
• [34]Rahman M, Islam MA, Mahalanabis D: Mothers' knowledge about vaccine preventable diseases and immunization coverage in a population with high rate of illiteracy. J Trop Pediatr 1995, 41:376-378.
• [35]Sheikh S, Ali A, Zaidi AK, Agha A, Khowaja A, Allana S, Qureshi S, Azam I: Measles susceptibility in children in Karachi Pakistan. Vaccine 2011, 29:3419-3423.
• [36]Giorgi Rossi P, Faustini A, Spadea T, Perucci CA: Choosing immunisation coverage indicators at the local level. Eur J Epidemiol 2004, 19:979-985.
• [37]Lessler J, Metcalf CJ, Grais RF, Luquero FJ, Cummings DA, Grenfell BT: Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. PLoS Med 2011, 8:e1001110.
• [38]Selimuzzaman A, Ullah M, Haque M: Accuracy of mothers' report regarding vaccination status of the children in urban Bangladesh. J Teach Assoc RMC, Rajshahi 2008, 21:40-43.
• [39]Lyratzopoulos G, Aston R, Bailey K, Flitcroft J, Clarke H: Accuracy of routine data on MMR vaccination coverage and validity of parental recall of vaccination. Commun Dis Public Health 2002, 5:305-310.
• [40]Hadler S, Dietz V, Okwo-Bele JM, Cutts F: Immunization in developing countries. In Vaccines. 5th edition. Edited by Plotkin SA, Orenstein WA, Offit PA. Philadelphia: Saunder Elsevier; 2008:1541-1571.
• [41]Vainio K, Samdal HH, Anestad G, Wedege E, Skutlaberg DH, Bransdal KT, Mundal R, Aaberge IS: Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts. Eur J Clin Microbiol Infect Dis 2008, 27:461-465.
• [42]Goyal A, Shaikh NJ, Kinikar AA, Wairagkar NS: Oral fluid, a substitute for serum to monitor measles IgG antibody? Indian J Med Microbiol 2009, 27:351-353.
• [43]Nigatu W, Nokes DJ, Enquselassie F, Brown DW, Cohen BJ, Vyse AJ, Cutts FT: Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 1999, 83:135-144.
• [44]Christie AS, Gay A: The measles initiative: moving toward measles eradication. J Infect Dis 2011, 204:S14-17.
• [45]Keegan R, Dabbagh A, Strebel PM, Cochi SL: Comparing measles with previous eradication programs: enabling and constraining factors. J Infect Dis 2011, 204:S54-61.
• [46]Hanvoravongchai P, Mounier-Jack S, Oliveira Cruz V, Balabanova D, Biellik R, Kitaw Y, Koehlmoos T, Loureiro S, Molla M, Nguyen H, et al.: Impact of measles elimination activities on immunization services and health systems: findings from six countries. J Infect Dis 2011, 204:S82-89.